Overview
Mark Jalkut is a Urologist in Raleigh, North Carolina. Dr. Jalkut is highly rated in 35 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Jalkut is currently accepting new patients.
His clinical research consists of co-authoring 10 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- MEDICARE MAPD
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3821 Ed Dr, Raleigh, NC 27612
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
Duke Ambulatory Surgery Center
My clinical interests include the minimally invasive management of urinary tract stones, including shock wave lithotripsy, percutaneous, and ureteroscopic stone removal. I completed my training at the University of North Carolina in 1983 and was an American Urological Association Scholar (1983-1985) in the Division of Mineral Metabolism at the University of Texas Southwestern Medical Center, Dallas. In 1993, I returned to North Carolina as professor of urological surgery and director of the Duke Comprehensive Kidney Stone Center. Dr. Preminger is highly rated in 19 conditions, according to our data. His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Boils, Lithotripsy, and Ureteroscopy.
Duke Cancer Center
I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case. Dr. George is highly rated in 17 conditions, according to our data. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy.
Duke Urology Clinic - Clinic 1G
I am a urologist who specializes in the medical and surgical management of kidney stones. My practice focuses on comprehensive kidney stone management. I perform a high volume of kidney stone surgeries, including cases with complex anatomy or large kidney stone burden. In addition, I perform evaluations to determine the cause of stones and then provide specific recommendations to prevent future stones. During our visit, I look forward to learning about you and obtaining a thorough history of your past experiences with kidney stones. After we review your laboratory results and imaging, we will discuss the best options to treat your current kidney stones and strategies to prevent them in the future. Dr. Antonelli is highly rated in 18 conditions, according to our data. Her top areas of expertise are Kidney Stones, Boils, Carbuncle, Ureteroscopy, and Lithotripsy.
Frequently Asked Questions about Dr. Mark W. Jalkut
How do I make an appointment with Dr. Mark W. Jalkut?
You can book an appointment with Dr. Mark W. Jalkut by calling their office at 919-758-8677. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark W. Jalkut a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark W. Jalkut is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark W. Jalkut specialize in?
While Dr. Mark W. Jalkut is a Urology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Mark W. Jalkut participate in research or clinical trials?
Yes. Dr. Mark W. Jalkut has published 10 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Mark W. Jalkut's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark W. Jalkut accept my insurance?
Dr. Mark W. Jalkut accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 919-758-8677 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Jalkut isDistinguished. Learn about Familial Prostate Cancer.
- Muscle Invasive Bladder CancerDr. Jalkut isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Jalkut isDistinguished. Learn about Prostate Cancer.
- Advanced
- Acute CystitisDr. Jalkut isAdvanced. Learn about Acute Cystitis.
- Bilateral HydronephrosisDr. Jalkut isAdvanced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Jalkut isAdvanced. Learn about Bladder Cancer.
- BoilsDr. Jalkut isAdvanced. Learn about Boils.
- CarbuncleDr. Jalkut isAdvanced. Learn about Carbuncle.
- Chromophobe Renal Cell CarcinomaDr. Jalkut isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Experienced
- Asymptomatic BacteriuriaDr. Jalkut isExperienced. Learn about Asymptomatic Bacteriuria.
- BalanitisDr. Jalkut isExperienced. Learn about Balanitis.
- Bladder Outlet ObstructionDr. Jalkut isExperienced. Learn about Bladder Outlet Obstruction.
- Bladder ReconstructionDr. Jalkut isExperienced. Learn about Bladder Reconstruction.
- Bladder StonesDr. Jalkut isExperienced. Learn about Bladder Stones.
- ChoriocarcinomaDr. Jalkut isExperienced. Learn about Choriocarcinoma.


